Opthea Limited
CKDXFOTCHealthcare● Active
$0.44
+$0.00(+0.00%)
Market Cap$601910336
P/E Ratio—
52W High$0.44
52W Low$0.29
Opthea Limited (CKDXF) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
CKDXF · earnings · updated Jun 8, 2026
Latest Earnings
Q3 FY2025Report Date: Aug 28, 2025EPS Actual
-$0.03
Est. -$0.01 · -197.0%
Revenue
$0.00B
Est. $0.00B · -99.0%
Fiscal Period
Q3 FY2025
FY ends December
Report Date
Aug 28, 2025
After Market Close
▼ Miss EPS▼ Miss Revenue
CKDXF reports quarterly as a OTC-listed Biotechnology company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Rev. $0.58B
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
Rev. Est.$0.58B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q1 FY2026 | Feb 26, 2026 | — | — | — | — | — | — |
| ▼ Q3 FY2025 | Aug 28, 2025 | -$0.01 | -$0.03 | -197.0% | $0.00B | $0.00B | -99.0% |
| ▼ Q1 FY2025 | Feb 26, 2025 | -$0.14 | -$0.19 | -41.9% | $0.00B | $0.00B | -68.5% |
| ▼ Q4 FY2024 | Oct 30, 2024 | -$0.05 | -$0.19 | -253.9% | $0.00B | $0.00B | +158.8% |
| ▼ Q2 FY2024 | Apr 29, 2024 | -$0.11 | -$0.25 | -127.4% | $0.00B | $0.00B | +272.7% |
| ▼ Q2 FY2023 | Jun 30, 2023 | -$0.06 | -$0.20 | -245.3% | $0.00B | $0.00B | -77.2% |
| ▼ Q4 FY2022 | Dec 31, 2022 | -$0.06 | -$0.23 | -292.9% | $0.00B | $0.00B | -78.4% |
| — Q2 FY2022 | Jun 30, 2022 | — | -$0.23 | — | $0.00B | — | — |
Q1 FY2026
Feb 26, 2026
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q3 FY2025
Aug 28, 2025Miss
EPS Actual
-$0.03
EPS Est.
-$0.01
EPS Surpr.
-197.0%
Revenue
$0.00B
Q1 FY2025
Feb 26, 2025Miss
EPS Actual
-$0.19
EPS Est.
-$0.14
EPS Surpr.
-41.9%
Revenue
$0.00B
Q4 FY2024
Oct 30, 2024Miss
EPS Actual
-$0.19
EPS Est.
-$0.05
EPS Surpr.
-253.9%
Revenue
$0.00B
Q2 FY2024
Apr 29, 2024Miss
EPS Actual
-$0.25
EPS Est.
-$0.11
EPS Surpr.
-127.4%
Revenue
$0.00B
Q2 FY2023
Jun 30, 2023Miss
EPS Actual
-$0.20
EPS Est.
-$0.06
EPS Surpr.
-245.3%
Revenue
$0.00B
Q4 FY2022
Dec 31, 2022Miss
EPS Actual
-$0.23
EPS Est.
-$0.06
EPS Surpr.
-292.9%
Revenue
$0.00B
Q2 FY2022
Jun 30, 2022
EPS Actual
-$0.23
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q2 FY2025 | $-0.01 | $-0.01 | $-0.01 | 1 |
| Q2 FY2024 | $-0.16 | $-0.16 | $-0.16 | 1 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q2 FY2025 | $0.0B | $0.0B | $0.0B | 1 |
| Q2 FY2024 | $0.0B | $0.0B | $0.0B | 1 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▼ Q3 FY2025 | Aug 28, 2025 | -197.0% | $0.44 | $0.44 | +0.00% |
| ▼ Q1 FY2025 | Feb 26, 2025 | -41.9% | $0.44 | $0.44 | +0.00% |
| ▼ Q4 FY2024 | Oct 30, 2024 | -253.9% | $0.57 | $0.57 | +0.00% |
| ▼ Q2 FY2024 | Apr 29, 2024 | -127.4% | $0.29 | $0.29 | +0.00% |
| ▼ Q2 FY2023 | Jun 30, 2023 | -245.3% | $0.42 | $0.42 | +0.00% |
| ▼ Q4 FY2022 | Dec 31, 2022 | -292.9% | $1.09 | $1.09 | +0.00% |
| — Q2 FY2022 | Jun 30, 2022 | — | $1.09 | $1.09 | +0.00% |
| ▼ Q4 FY2021 | Dec 31, 2021 | -88.1% | $1.09 | $1.09 | +0.00% |
Q3 FY2025+0.00%
Report Date
Aug 28, 2025
EPS Beat/Miss
-197.0%
Price Before
$0.44
Price After
$0.44
Q1 FY2025+0.00%
Report Date
Feb 26, 2025
EPS Beat/Miss
-41.9%
Price Before
$0.44
Price After
$0.44
Q4 FY2024+0.00%
Report Date
Oct 30, 2024
EPS Beat/Miss
-253.9%
Price Before
$0.57
Price After
$0.57
Q2 FY2024+0.00%
Report Date
Apr 29, 2024
EPS Beat/Miss
-127.4%
Price Before
$0.29
Price After
$0.29
Q2 FY2023+0.00%
Report Date
Jun 30, 2023
EPS Beat/Miss
-245.3%
Price Before
$0.42
Price After
$0.42
Q4 FY2022+0.00%
Report Date
Dec 31, 2022
EPS Beat/Miss
-292.9%
Price Before
$1.09
Price After
$1.09
Q2 FY2022+0.00%
Report Date
Jun 30, 2022
EPS Beat/Miss
—
Price Before
$1.09
Price After
$1.09
Q4 FY2021+0.00%
Report Date
Dec 31, 2021
EPS Beat/Miss
-88.1%
Price Before
$1.09
Price After
$1.09
Avg Miss Reaction+0.00%
Beat Rate0 / 8 quarters
Largest Move+0.00% (Q3 FY2025)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: CKDXF ends December
Opthea Limited (CKDXF) most recently reported earnings on August 28, 2025 for Q3 FY2025, posting EPS of $-0.03 — missing the analyst consensus of $-0.01 by -197.0%. The next CKDXF earnings date is expected around September 1, 2026.
Each quarter, investors track CKDXF earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. CKDXF revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
CKDXF's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
CKDXF earnings · 5 questionsOpthea Limited's next earnings report is expected around September 1, 2026. CKDXF typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; CKDXF historically reports after market close (AMC).
CKDXF earnings datewhen is CKDXF earningsCKDXF next earnings datewhen does CKDXF report earningsCKDXF earnings calendar
▸ Source: FMP · Opthea Limited SEC filings · US GAAP · Opthea Limited SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026